Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501. Case and Commentary Oct 2019 How Should Clinical Ethics Consultants Support Parents’ Decision Making? Katherine J. Feder, MS and Janice I. Firn, PhD, LMSW Rather than relying on decision aids, values-based approaches to decision making illuminate a plurality of possible right actions. AMA J Ethics. 2019;21(10):E831-837. doi: 10.1001/amajethics.2019.831. In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Current page 13
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501.
Case and Commentary Oct 2019 How Should Clinical Ethics Consultants Support Parents’ Decision Making? Katherine J. Feder, MS and Janice I. Firn, PhD, LMSW Rather than relying on decision aids, values-based approaches to decision making illuminate a plurality of possible right actions. AMA J Ethics. 2019;21(10):E831-837. doi: 10.1001/amajethics.2019.831.
In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.